NCT06833606 Diagnosis and Outcomes of Placental Accretism
| NCT ID | NCT06833606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Placenta Accreta |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-07-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2023-07-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the diagnostic ability of the main criteria currently adopted for the diagnosis of placenta accreta and to define the maternal outcomes in terms of complications of the different management strategies currently adoptable when placental accretism is suspected.
Eligibility Criteria
Inclusion Criteria: * Age between 18 years and 44 years * Pregnant women with suspected placental accretism * Acquisition of informed consent form Exclusion Criteria: None
Contact & Investigator
Gianluigi Pilu, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06833606 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 44 Years, studying Placenta Accreta. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06833606 currently recruiting?
Yes, NCT06833606 is actively recruiting participants. Contact the research team at gianluigi.pilu@aosp.bo.it for enrollment information.
Where is the NCT06833606 trial being conducted?
This trial is being conducted at Bologna, Italy, Cesena, Italy, Forlì, Italy, Modena, Italy and 3 additional locations.
Who is sponsoring the NCT06833606 clinical trial?
NCT06833606 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Gianluigi Pilu, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 70 participants.